Newborn screening in Taiwan: Q&A with Dr Yin-Hsiu (Nancy) Chien

C.Yin-HsiuC.Yin-Hsiu
BulletArticle
Newborn Screening Rare Diseases
Bagikan:
Salin tautan
Newborn screening in Taiwan: Q&A with Dr Yin-Hsiu (Nancy) Chien

As Director of the Newborn Screening Centre at National Taiwan University Hospital, Dr Yin-Hsiu (Nancy) Chien is at the forefront of Taiwan’s newborn screening (NBS) efforts. In this Q&A, we speak with Dr Chien about how NBS works in Taiwan, drawing upon her experience as a clinician-researcher and lab director to explore key considerations around panel composition, sample collection, lab workflows, and hopes for the future of NBS.

Bagikan:
Salin tautan

Lainnya dalam topik yang sama

Should newborn screening include chromosome 15q disorders?

How Early Check shapes newborn screening policy with better evidence

Rekomendasi topik

SequencingRED 2020Rare Diseases
Bacaan Berikutnya
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
3 steps to mitigate the impact of interference
  • Clinician Engagement, Coagulation, Disease Area, Management
3 steps to mitigate the impact of interference
A guide to balancing quality, speed and cost
  • Operational Excellence, Operations
A guide to balancing quality, speed and cost
Scroll to Top